Treatment of Parkinson's disease is in large part based on the administration of levodopa. The use of this drug is limited by the development of psychiatric complications, including a disorder similar ...

A study involving 22 Parkinson's disease (PD) patients has shown that use of the dopaminergic drug levodopa improves sleep quality. When the patients took the drug, the number of times they woke up ...

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Carbidopa, Levodopa and Entacapone Tablets, 12.5 ...

As multiple drugmakers race to bring novel, levodopa-based Parkinson’s disease treatments to the market, New Jersey’s Amneal Pharmaceuticals has taken home the gold in the U.S. Late Wednesday, the FDA ...

A study involving 22 Parkinson’s disease (PD) patients has shown that use of the dopaminergic drug levodopa improves sleep quality. When the patients took the drug, the number of times they woke up ...

Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's drug levodopa. University of Arizona researchers have revealed new insights ...

CREXONT ® is a novel, oral formulation of carbidopa/levodopa (CD/LD) capsule that combines both immediate-release granules and extended-release beads for the treatment of Parkinson’s disease. CREXONT ...

Alembic Pharmaceuticals Ltd on Friday said it has received approval from the US health regulator for its generic version of ...

Alembic Pharmaceuticals receives USFDA approval for generic Carbidopa, Levodopa, and Entacapone tablets to treat Parkinson's ...